MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Utility of neurophysiological markers in clinical management of subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson’s disease (PD)-a case report.

    K. Markopoulou, P. Warnke (Evanston, USA)

  • Utility of quantitative EEG during sleep as a potential biomarker of Lewy body disease progression

    E. Matar, K. Ehgoetz Martens, R. Grunstein, A. D'Rozario, S. Lewis (Sydney, Australia)

  • Utilization pattern and factors associated with amantadine use in Parkinson’s disease (PD) of the French NS-Park cohort

    M. Fabbri, S. Tessier, V. Rousseau, JC. Corvol, A. Sommet, F. Tubach, Y. de Rycke, N. Bertille, Y. Selvarasa, S. Carvalho, C. Brefel-Courbon, F. Ory-Magne, O. Rascol (Blagnac, France)

  • Utilizing Speech Analysis to Differentiate Progressive Supranuclear Palsy from Parkinson Disease

    K. Kang, A. Nunes, M. Sharma, A. Hall, R. Mishra, J. Casado, R. Cole, G. Barchard, A. Vaziri, A. Wills, A. Pantelyat (Baltimore, USA)

  • Vaccination from Covid-19 in people with Parkinson`s disease

    J. Salimjonov, N. Rashidova, K. Khalimova, R. Matmurodov (Tashkent, Uzbekistan)

  • Vagus nerve degeneration in Parkinson’s disease: correlation with autonomic symptoms and pupillography

    M. Batchakaschvili, M. Löhle, HR. Kleinlein, W. Hermann, H. Walter, A. Storch, U. Walter (Rostock, Germany)

  • Validating A New Writer’s Cramp Impairment Scale

    E. Shamim, G. Stebbins, B. Hodsdon, K. Alter, B. Karp, O. Ahmad, P. Srivanitchapoom, K. Mente, C. Toro, S. Meunier, M. Hallett (Rockville, USA)

  • Validating wearable sensors as an assessment tool for Parkinson’s Disease

    K. Silis, N. Kieran, N. Shawki, S. Madarshahian, M. Serruya, T. Liang (Philadelphia, USA)

  • Validation and psychometric properties of the Thai version of the hemifacial spasm grading questionnaire (HFS score) for physician-assessed clinical involvement and patient-reported health-related quality of life: a prospective observational study

    ���N. Likhitwitayawuid, Y. Pitakpatapee, W. Saengphatarachai, P. Srivanitchapoom (Bangkok, Thailand)

  • Validation and replication of Parkinson disease behavioral subtypes

    C. Lessov-Schlaggar, P. Myers, J. Jackson, B. Maiti, P. Kotzbauer, J. Perlmutter, M. Campbell (St. Louis, USA)

  • « Previous Page
  • 1
  • …
  • 179
  • 180
  • 181
  • 182
  • 183
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • #25136 (not found)
  • Unusual prolonged survival in multiple system atrophy: A case report
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley